The EU Commission publishes its preliminary report on its competition enquiry into the pharmaceutical sector

The relationship between competition law and intellectual property rights has been the subject of much debate during the European Commission’s on-going pharmaceutical sector enquiry. In particular, there has been some concern that competition law could encroach on the complex rules governing patents and innovation. With the recent publication of a submission made by the European Patent Office (EPO) to the Commission in connection with its enquiry, this debate has once again come to the fore. The EPO’s submission queries several aspects of the Commission’s preliminary findings and warns against upsetting some of the principles and procedures of patentability. The Commission published its preliminary report on its competition enquiry into the pharmaceutical sector on 28 November 2008. The

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • Court of First Instance of Namur (Namur)

Citation

Martin Favart, The EU Commission publishes its preliminary report on its competition enquiry into the pharmaceutical sector, 28 novembre 2008, e-Competitions November 2008, Art. N° 44970

Visites 169

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues